On March 3, 2025, Apogee Therapeutics announced its financial results for the year ended December 31, 2024, and positive interim Phase 1 results from its trial of APG990, with a webcast scheduled for the same day to discuss the data.
AI Assistant
APOGEE THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.